Delain, M <br/><br/>
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.  [electronic resource] 

 -  Leukemia & lymphoma  Jul 1999 
 - 305-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199909050955  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--therapeutic use<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Etoposide--therapeutic use<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Hodgkin Disease--therapy<br/>Humans<br/>Ifosfamide--therapeutic use<br/>Male<br/>Mechlorethamine--therapeutic use<br/>Middle Aged<br/>Mitoguazone--therapeutic use<br/>Outcome Assessment, Health Care<br/>Prednisolone--therapeutic use<br/>Prednisone--therapeutic use<br/>Procarbazine--therapeutic use<br/>Prognosis<br/>Prospective Studies<br/>Vinblastine--analogs & derivatives<br/>Vincristine--therapeutic use